ActHIB set to finally reach the Japanese market
This article was originally published in Scrip
Executive Summary
The much-delayed Japanese launch of Sanofi Pasteur-Daiichi Sankyo Vaccines' paediatric meningitis vaccine ActHIB will take place on December 19th. The Haemophilus influenzae type b prophylactic vaccine was approved in the country back in January 2007, but batch production to Japanese standards took longer than expected. The product will be distributed by Daiichi Sankyo, and is not currently eligible for reimbursement under Japan's national insurance scheme.
The much-delayed Japanese launch of Sanofi Pasteur-Daiichi Sankyo Vaccines' paediatric meningitis vaccine ActHIB will take place on December 19th. The Haemophilus influenzae type b prophylactic vaccine was approved in the country back in January 2007, but batch production to Japanese standards took longer than expected. The product will be distributed by Daiichi Sankyo, and is not currently eligible for reimbursement under Japan's national insurance scheme.